PHYT​OMEDICINE FOR H​UMA​NITY

INTL directors
 Join us  Support our cause

Non-US Nations

A Non-Profit Orga​nization (Pending)  
Fighting Diseases with Drug-Free Phytomedicine 

 - Organization & Products under Development -  

Diabetes Type II: REDUCTION OF
GLUCOSE with  
Drug-Free Phytomedicine

Diabetes is the 7th rank mortality rate and a sad problem for the US medically and economically. It is largely cause by a lifestyle filled with junk and processed food profiteered by big corporations who could care less about their own people. 60% of US diabetes patients will die earlier than while 80% will suffer other consequences from diabetes drugs themselves:  Slfonylureas, Dypeptidyl Peptidase-4, Dopamine agonist, Sodium Glucose Inhibitor: None target glucose but manipulate the pancreas, hormones, brain and other organs. Prolonged usage will  bring  inevitable bio consequences even death.

Medically, if high glucose in blood, the most logical objective for medicine is to target and remove, reduce glucose, while strengthening the organs and hormones to support the digestive and metabolism system to remove glucose rather than to manipulate the body itself. The patient must improve their lifestyle and society must lessen their junk/processed food.  Our Phytomedicine remedy will target and alleviate glucose in the blood itself and not targeting our own body like drugs do. It will be a multi-front process to help the body get rid of sugar in 6 to 12 months. The process is simple, painless and effective without more chemicals that would kill the patients first before diabetes do.

Development Team

Lead Scientist:

Endocrinologist:


Contributing Scientistis:











Research Coordinator:

ATHAR ATA, Department of Chemistry, Richardson College 
 The University of  Winnipeg, Winnipeg, Canada
Sheela. D and Uthayakumari Kalavathy, Dept of Botany 
Mary’s College. (Autonomous), Thoothukudi. Tamilnadu, India.
Saritha Marella, Naga Venkata Nanotechnology Laboratory, Institute of Frontier Technology, Regional Agricultural Research Ranga Agricultural  University, India
Polyxeni Alexiou and Vassilis J. Demopoulos
Department of Pharmaceutical Chemistry, School of Pharmacy
Aristotle University of Thessaloniki, Greece

FOR 60 YEARS, WE HAVE BEEN USING DIABETES DRUGS 
THAT COULD BE DANGEROUS TIME BOMBS TO THE PATIENTS

dIABETES MEDICATIONS THAT CAN BE JUST AS DANGEROUS AS DIABETES

Diabetes is detrimental to one's health. But some of the medications we prescribed to them, though can stop diabetes temporarily, they can be just as dangerous as Diabetes itself

DIABETES DRUG GROUP A

Sulfonylureas

Sulfonylureas exists for over 60 years under 15 Brands, acting upon Beta Cells in the Pancreas in patients with residual B-cell activity to produce insulin to lower Glucagon in blood.  First, continued action upon any hormone system that will lead to unknown changes in the body. Secondly, ​high risk of Hypoglycaemia is common with long-acting sulfonylureas. Other risks are impaired renal or hepatic function with Sulfonylureas. Third, it can cause many harmful heart problems: There is growing evidence that patients taking sulfonylureas are more likely to have a heart attack or die from heart issues than from Diabetes.

https://care.diabetesjournals.org/content/40/5/706  
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1329456/ 

DIABETES DRUG gROUP b

Dypeptidyl Peptidase-4

DPP-4 enzyme acts on incretin hormones, GLP-1 and GIP to increase insulin secretion and decreasing glucagon secretion. GLP-1 hormone by endocrine L cells to lower glucose by insulin secretion. The 1st effect is that delaying stric emptying  can cause severe joint pain. DPP-4 also cause acute inflammation of the pancreas, low blood sugar and severe allergy if combined with other prescriptions.  Most common side effects are upper respiratory tract infection, nasopharyngitis, headache, urinary tract infection,  arthralgia.
There are also reports of hypersensitivity reactions such as anaphylaxis and angioedema, Stevens-Johnson syndrome,  including fatal hemorrhagic or necrotizing variants.

https://www.ncbi.nlm.nih.gov/books/NBK542331/  

DIABETES DRUG GROUP  c

Dopamine Agonists Bromocriptine, Bromergocryptine

Dopamine is a neurotransmitter regulating movement, cognition, memory, learning, sleep, and food intake. Dopamine inhibits the synthesis and secretion of hormone Prolactin from the pituitary gland affecting cardio-vascular, kidney, pancreas, and gastrointestinal system. Dopamine such as Bromocriptine also used for Parkinson, Dystonia, Dyskinesia, infertility, sex drive, etc. Regulating Dopamine could expose patients to irreversible nerve conditions from insomina, delirium, depression, infertility and cancer. The manipulation of such hormone in the brain is reckless because it creates pathogenic conditions harder to treat than diabetes itself. In contrast, the goal and mechanism of our phytomedicine is simple: To target the pathogen - Glucose -  while supporting and rebuilding other body functions and internal organs instead of  addting more damages.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152192/ https://www.ncbi.nlm.nih.gov/books/NBK551686/ https://n.neurology.org/content/lewy-body-disease-and-suicidality-after-dopamine-agonist-withdrawal  

 

DIABETES DRUG gROUP D

Sodium Glucose Transporter Inhibitor  

SGLT2 inhibitors are a FDA-approved to lower blood sugar recently since 2009 under drugs named canagliflozin, dapagliflozin, and empagliflozin. While clinical trials show the most common side effects are relatively minor, most experts fear that side effects could be more serious. FDA's FAERS (adverse effects report network) shows some serious, even fatal side effects of ketoacidosis — a condition where a lack of insulin causes acid to build up leadinig to fungal infections, kidney, urinary injuries, dyslipidemia (increase in cholesterol) genital infections and Fungal Fournier’s Gangrene of the genitalia. The prolonged presence of acid in the blood is a single most danger diabetes patients with SGLT2 Inhibitors. 

The above examples illustrate again the serious side effects of many diabetes drugs because they always attempt to manipulate the body instead of targeting glucose in the blood.